Sloning and Research & Innovation Japan Announce Distribution Partnership
News Jul 20, 2007
Sloning Biotechnology has announced a distribution partnership with Research & Innovation Japan Inc. (RIJ).
RIJ will exclusively market and sell Sloning´s gene synthesis service (Slonomics™) and the product family of gene mutant libraries (Slonomax™) in Japan.
“We are very pleased that RIJ will join our global network of qualified distributors. Their technological strength and market awareness makes RIJ the ideal partner to co-develop the Japanese market.” stated Thomas Matthes, the company CBO.
Kiyohiko Hirasawa, founder and CEO of RIJ said “Sloning´s products and services perfectly addressing the current demand in genomics research and protein engineering. We are looking forward to represent Sloning in Japan”.
Some MRSA infections could be tackled using widely-available antibiotics, suggests new research. A team of scientists used genome sequencing technology to identify which genes make MRSA susceptible to a previously defined combination of drugs. They identified a number of mutations centered around a protein known as a penicillin-binding protein 2a or PBP2a.